跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALEVE naproxen sodium 220 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ALEVE naproxen sodium 220 mg tablet blister pack
Approved
STANDARD
ALEVE naproxen sodium 220 mg tablet blister pack
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
5755229f5b53ce04
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
5755229f5b53ce04
Product Name
ALEVE naproxen sodium 220 mg tablet blister pack
Artg Id
63794
Artg Name
ALEVE naproxen sodium 220 mg tablet blister pack
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
1998-06-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
5755229f5b53ce04
Type
Standard
Back to TGA Approvals
